Clinical Trials Directory

Explore 21,535 clinical trials worldwide

Showing 8901-8950 of 21,535 trials

Active filters:Status: Active, not recruiting

Clinical Trials (21,535)

NCT05371041
Tourette Deep Brain Stimulation (DBS) Target Detection & Suppression
NAActive, not recruiting
8 participants
Started: Jun 20, 2022 · Completed: Aug 31, 2026
1 condition2 sponsors1 location
NCT05411497
Genetically Engineered Cells (MUC1-Activated T-Cells) for the Treatment of MUC1 Positive Recurrent or Refractory Multiple Myeloma
PHASE1Active, not recruiting
5 participants
Started: Jun 20, 2022 · Completed: Aug 18, 2028
2 conditions1 sponsor2 locations
NCT05444491
Application of Polygenic Methylation Markers in Postoperative Recurrence Monitoring of Colorectal Cancer
N/AActive, not recruiting
800 participants
Started: Jun 20, 2022 · Completed: Jun 30, 2026
1 condition2 sponsors7 locations
NCT05438719
MOTUS Total Joint Replacement Investigational Device Exemption Study
NAActive, not recruiting
158 participants
Started: Jun 20, 2022 · Completed: Jun 13, 2029
1 condition1 sponsor14 locations
NCT04772222
Dexmedetomidine Use in Infants Undergoing Cooling Due to Neonatal Encephalopathy (DICE Trial)
PHASE2Active, not recruiting
50 participants
Started: Jun 20, 2022 · Completed: Dec 31, 2025
2 conditions1 sponsor5 locations
NCT05172960
ALLIANCE: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve
NAActive, not recruiting
915 participants
Started: Jun 20, 2022 · Completed: Dec 31, 2034
1 condition1 sponsor65 locations
NCT05434702
"COACH Study: Individualized COaching in Young Adult Cancer Survivors to Encourage Healthy Behaviors"
N/AActive, not recruiting
100 participants
Started: Jun 20, 2022 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT05431608
A Study of MCARH109 and MCARH125 in People With Multiple Myeloma
PHASE1Active, not recruiting
15 participants
Started: Jun 20, 2022 · Completed: Jun 20, 2026
3 conditions1 sponsor7 locations
NCT05181618
A Study to Evaluate Overall Health, Physical Activity, and Joint Outcomes in Participants With Severe or Moderate Hemophilia A Without Factor VIII Inhibitors on Emicizumab Prophylaxis
PHASE4Active, not recruiting
136 participants
Started: Jun 20, 2022 · Completed: May 21, 2027
2 conditions1 sponsor27 locations
NCT05089370
Oral Decitabine/Cedazuridine (DEC-C) in Combination With Nivolumab for Patients With Mucosal Melanoma
PHASE1/PHASE2Active, not recruiting
8 participants
Started: Jun 20, 2022 · Completed: Oct 31, 2026
1 condition3 sponsors1 location
NCT05434741
Cognitive Behavior Therapy (CBT)-Based Group Intervention to Reduce Inflammation in Older People With HIV
NAActive, not recruiting
50 participants
Started: Jun 20, 2022 · Completed: Jun 30, 2024
2 conditions1 sponsor1 location
NCT05251454
Studying the Effects of Brain Stimulation on Cognitive Control and Associated EEG in Human Subjects.
NAActive, not recruiting
5 participants
Started: Jun 20, 2022 · Completed: Dec 30, 2025
1 condition1 sponsor1 location
NCT05269732
CBT for Postpartum Depression and Infant Emotion Regulation
NAActive, not recruiting
172 participants
Started: Jun 17, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06196801
Efficacy of Triple-Combination Therapy in Severe PAH-CHD
N/AActive, not recruiting
80 participants
Started: Jun 17, 2022 · Completed: Dec 1, 2025
2 conditions1 sponsor1 location
NCT05296148
A Feasibility Study of the CroíValve DUO System for Tricuspid Regurgitation
NAActive, not recruiting
10 participants
Started: Jun 17, 2022 · Completed: Jul 31, 2026
1 condition1 sponsor3 locations
NCT05376579
Impact of Mayzent on aSPMS Patients in a Long-term NIS in Italy
N/AActive, not recruiting
134 participants
Started: Jun 17, 2022 · Completed: Jun 30, 2026
1 condition1 sponsor24 locations
NCT05155891
Investigation of Prostate Artery Embolization Compared to Holmium Laser Enucleation of Prostate
NAActive, not recruiting
45 participants
Started: Jun 17, 2022 · Completed: Jan 1, 2027
1 condition1 sponsor1 location
NCT05361668
Study to Evaluate the Safety, PK, and Dose Response of Paltusotine in Subjects With Carcinoid Syndrome
PHASE2Active, not recruiting
36 participants
Started: Jun 17, 2022 · Completed: Feb 28, 2026
9 conditions1 sponsor35 locations
NCT05335369
A Patient-Centered Communication Tool (UR-GOAL) Versus Usual Care for Older Patients With Acute Myeloid Leukemia, Their Caregivers, and Their Oncologists
NAActive, not recruiting
100 participants
Started: Jun 17, 2022 · Completed: Oct 31, 2025
1 condition1 sponsor1 location
NCT05269745
Influence of Immobilisation, Stretching and Activity on Morphological and Mechanical Properties of Spastic Muscle
NAActive, not recruiting
20 participants
Started: Jun 17, 2022 · Completed: Sep 30, 2024
1 condition2 sponsors1 location
NCT05270837
Study to Evaluate the Safety and Efficacy of Pegvaliase in Adolescents (Ages 12-17) With Phenylketonuria
PHASE3Active, not recruiting
55 participants
Started: Jun 17, 2022 · Completed: Oct 31, 2027
1 condition1 sponsor16 locations
NCT05382325
A Study of MK-1484 as Monotherapy and in Combination With Pembrolizumab (MK-3475) In Advanced or Metastatic Solid Tumors (MK-1484-001)
PHASE1Active, not recruiting
70 participants
Started: Jun 16, 2022 · Completed: Jul 31, 2026
1 condition1 sponsor8 locations
NCT05368844
Transcranial Magnetic Stimulation (TMS) in the Treatment of Anorexia Nervosa
NAActive, not recruiting
40 participants
Started: Jun 16, 2022 · Completed: Oct 1, 2026
1 condition1 sponsor1 location
NCT04590872
An Immunotherapy Vaccine (PIpepTolDC) for the Treatment of Patients With Type 1 Diabetes
PHASE1Active, not recruiting
6 participants
Started: Jun 16, 2022 · Completed: Dec 16, 2025
1 condition1 sponsor1 location
NCT05386576
A Study of Venetoclax in Combination With Chemotherapy to Treat Newly Diagnosed Acute Lymphoblastic Leukemia (ALL)
EARLY_PHASE1Active, not recruiting
12 participants
Started: Jun 16, 2022 · Completed: May 31, 2026
1 condition2 sponsors1 location
NCT06605313
SQ-Kyrin-T First-in-man Feasibility Study
NAActive, not recruiting
12 participants
Started: Jun 16, 2022 · Completed: Nov 24, 2027
1 condition1 sponsor1 location
NCT05395663
Scalability of a Home Health Navigator Program to Reduce Arsenic, Nitrate, and Lead in Private Well Water
NAActive, not recruiting
98 participants
Started: Jun 16, 2022 · Completed: Jun 30, 2025
1 condition3 sponsors1 location
NCT05662098
Alternative Dosing And Prevention of Transfusions (ADAPT)
EARLY_PHASE1Active, not recruiting
100 participants
Started: Jun 16, 2022 · Completed: Dec 31, 2027
1 condition2 sponsors1 location
NCT05628337
The TEACH (Texting After ACS Discharge) Pilot Randomized Trial
NAActive, not recruiting
241 participants
Started: Jun 16, 2022 · Completed: Jul 31, 2025
1 condition1 sponsor1 location
NCT05232851
A Vaccine (PDS0101) Alone or in Combination With Pembrolizumab for the Treatment of Locally Advanced Human Papillomavirus-Associated Oropharynx Cancer
PHASE1/PHASE2Active, not recruiting
24 participants
Started: Jun 16, 2022 · Completed: Oct 1, 2026
5 conditions1 sponsor1 location
NCT05614336
COVID-19 Antibody Responses in Cystic Fibrosis
NAActive, not recruiting
331 participants
Started: Jun 15, 2022 · Completed: Jun 30, 2025
2 conditions2 sponsors9 locations
NCT05288751
Contingency Management for Opioid and Stimulant Use Disorders in Primary Care
NAActive, not recruiting
56 participants
Started: Jun 15, 2022 · Completed: Aug 31, 2026
2 conditions1 sponsor1 location
NCT06295081
TREAT Study - Improving the Interpretation of Troponin Concentrations Following Exercise and Their Clinical Significance
N/AActive, not recruiting
1,015 participants
Started: Jun 15, 2022 · Completed: Jul 1, 2044
1 condition2 sponsors1 location
NCT05291871
Immunogenicity of Fractional Dose of the HPV Vaccines
PHASE4Active, not recruiting
92 participants
Started: Jun 15, 2022 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT05220358
Changes in Immunologic Parameters Following the Addition of Fostemsavir in Virologically Suppressed Immunologic Non-responders Living With HIV-the RECOVER Study
PHASE4Active, not recruiting
25 participants
Started: Jun 15, 2022 · Completed: Feb 13, 2026
1 condition2 sponsors1 location
NCT06320418
The Epigenetic Regulatory Role of P-element Induced Wimpy Testis (Piwi) Interacting RNA-823 (piR-823) in Ovarian Cancer Progression
N/AActive, not recruiting
56 participants
Started: Jun 15, 2022 · Completed: Jun 30, 2024
1 condition1 sponsor1 location
NCT05416437
Breathlessness Relieved by Employing Medical Air to be Titrated by Hospitalized Patients to Improve Inpatient Experience
NAActive, not recruiting
80 participants
Started: Jun 15, 2022 · Completed: Jun 30, 2025
1 condition1 sponsor1 location
NCT05406674
Body Surface Area-based vs Concentration-based Dosing of Cisplatin for Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Women With Advanced Ovarian Cancer
PHASE2Active, not recruiting
40 participants
Started: Jun 15, 2022 · Completed: Dec 31, 2027
3 conditions1 sponsor2 locations
NCT05140876
Supporting Treatment Adherence for Resilience and Thriving (START)
NAActive, not recruiting
286 participants
Started: Jun 15, 2022 · Completed: Jul 31, 2026
3 conditions2 sponsors1 location
NCT05336786
Prostate Cancer Diagnosis by Multiparametric Ultrasound (Wholemount)
PHASE3Active, not recruiting
70 participants
Started: Jun 15, 2022 · Completed: May 26, 2026
1 condition2 sponsors2 locations
NCT05132075
Study of JDQ443 in Comparison With Docetaxel in Participants With Locally Advanced or Metastatic KRAS G12C Mutant Non-small Cell Lung Cancer
PHASE3Active, not recruiting
95 participants
Started: Jun 15, 2022 · Completed: Mar 30, 2026
1 condition1 sponsor53 locations
NCT05437757
Scaffold-guided Breast Surgery
NAActive, not recruiting
19 participants
Started: Jun 15, 2022 · Completed: Dec 17, 2025
2 conditions1 sponsor1 location
NCT06456294
Evaluation of a Medication Health Center to Promote Opioid Safety
NAActive, not recruiting
14 participants
Started: Jun 15, 2022 · Completed: Jan 1, 2025
1 condition1 sponsor1 location
NCT05369208
Evaluation of Avatrombopag for the Treatment of Thrombocytopenia in Japanese Adults With Chronic ITP
PHASE3Active, not recruiting
19 participants
Started: Jun 15, 2022 · Completed: Oct 31, 2025
1 condition1 sponsor19 locations
NCT05046171
Decreasing Polypharmacy in Older Adults With Curable Cancers Trial
PHASE1/PHASE2Active, not recruiting
80 participants
Started: Jun 14, 2022 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT05460169
Renal Denervation in ADPKD- RDN-ADPKD Study
NAActive, not recruiting
44 participants
Started: Jun 14, 2022 · Completed: Mar 31, 2028
3 conditions1 sponsor1 location
NCT04850599
Isatuximab, Carfilzomib, and Pomalidomide for the Treatment of Relapsed or Refractory Multiple Myeloma
PHASE2Active, not recruiting
5 participants
Started: Jun 14, 2022 · Completed: Feb 21, 2029
2 conditions3 sponsors1 location
NCT05393674
Fedratinib in Combination with Nivolumab
PHASE2Active, not recruiting
30 participants
Started: Jun 14, 2022 · Completed: Jun 30, 2026
2 conditions3 sponsors7 locations
NCT05295225
Green Light Exposure in Healthy Volunteers Exposure in Normal Human Volunteers
NAActive, not recruiting
30 participants
Started: Jun 14, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05426369
A Clinical Trial Evaluating SCB-219M in in Chemotherapy-induced Thrombocytopenia (CIT)
PHASE1Active, not recruiting
36 participants
Started: Jun 14, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location